Invenra Inc.
Bispecific antibody discovery and development platform
- Sector
- Biotech
- Headquarters
- MADISON, WI
- Founded
- 2011
- Latest Form D
- $7.1M, Oct 2018
- Total capital
- $21.3M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $21.3M
- 7 Form D · last Oct 2018
- 96 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 38 pending · first 2017
- Rank in peer group#59 of 342
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 7th filing$7.1M
- Private capital raisedForm D · SEC · 6th filing$2.9M
- Private capital raisedForm D · SEC · 5th filing$3M
- Private capital raisedForm D · SEC · 4th filing$2M
- Private capital raisedForm D · SEC · 3rd filing$2M
- Private capital raisedForm D · SEC · 2nd filing$3M
- Private capital raisedForm D · SEC · 1st filing$1.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 342 peers
Line = medianBiotech · Platform
- Granted patents#59 · top 17%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- David SnyderDirectorNamed in SEC Form D filings
- Emile NuwaysirDirectorNamed in SEC Form D filings
- Paul WeissDirectorNamed in SEC Form D filings
- Richard LesniewskiDirectorNamed in SEC Form D filings
- Roland GreenExecutive Officer, DirectorNamed in SEC Form D filings
- Stan RoseDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 40- PendingAntibody ConstructsUSPTOApplication 19275881
- PendingOrthogonal Mutations For HeterodimerizationUSPTOApplication 19190527
- PendingMultispecific Binding Agents That Target B7H3 And GD2 And Uses ThereofUSPTOApplication 18980705
Show all 40 patent records
- Antibody ConstructsJul 2, 2026 · Application 19275881Pending
- Orthogonal Mutations For HeterodimerizationMar 19, 2026 · Application 19190527Pending
- Multispecific Binding Agents That Target B7H3 And GD2 And Uses ThereofNov 20, 2025 · Application 18980705Pending
- Orthogonal Mutations For HeterodimerizationMay 27, 2025 · US 12,312,418Granted
- Trivalent Trispecific Antibody ConstructsJan 23, 2025 · Application 18335995Pending
- Antibody ConstructsFeb 8, 2024 · Application 18055720Pending
- Multispecific Treg Binding MoleculesJul 7, 2022 · Application 17264735Pending
- Multivalent Receptor-clustering Agonist Antibody ConstructsNov 25, 2021 · Application 16641605Pending
- Trivalent Trispecific Antibody ConstructsJun 17, 2021 · Application 17048482Pending
- Binding MoleculesJun 3, 2021 · Application 17048508Pending
- Antibody ConstructsMay 3, 2018 · Application 15787640Pending
- High Throughput Screen For Biologically Active PolypeptidesJul 11, 2017 · US 9,701,959Granted
- Multispecific Binding Agents That Target CD25 And/or CTLA4 And Uses ThereofApplication 63352210Pending
- Multispecific Binding Agents That Target B7H3 And GD2 And Uses ThereofApplication 63352208Pending
- Orthogonal Mutations For HeterodimerizationApplication PCTUS2021062951Pending
- Bispecific GD2 And B7H2 Binding Molecules And Methods Of UseApplication PCTUS2021018939Pending
- Orthogonal Mutations For HeterodimerizationApplication 63123915Pending
- Bispecific GD2 And B7H3 Binding MoleculesApplication 62979245Pending
- Multivalent Receptor-clustering Agonist Antibody Constructs And Antigen Binding ProteinsApplication PCTUS2019061660Pending
- Multispecific Treg Binding MoleculesApplication PCTUS2019043958Pending
- Trivalent Trispecific Antibody ConstructsApplication PCTUS2019027816Pending
- Binding MoleculesApplication PCTUS2019027991Pending
- Multispecific Antibody Purification With CH1 ResinApplication PCTUS2019023447Pending
- Combination TherapyApplication 62812165Pending
- Multivalent Receptor-clustering Agonist Antibody ConstructsApplication 62811929Pending
- Multivalent Receptor-clustering Agonist Antibody ConstructsApplication 62768009Pending
- Multivalent Receptor-clustering Agonist Antibody ConstructsApplication PCTUS2018047819Pending
- Multispecific Treg Binding MoleculesApplication 62712077Pending
- Binding MoleculesApplication 62659079Pending
- Trivalent Trispecific Antibody ConstructsApplication 62659047Pending
- Multispecific Antibody Purification With CH1 ResinApplication 62646316Pending
- Multivalent Receptor-clustering Agonist Antibody ConstructsApplication 62646321Pending
- Antibody ConstructsApplication PCTUS2017057268Pending
- Antibody ConstructsApplication 62555498Pending
- Multivalent Receptor-clustering Agonist Antibody ConstructsApplication 62549913Pending
- Antibody ConstructsApplication 62549894Pending
- Antibody ConstructsApplication 62410054Pending
- Methods, Apparatus And Compositions For Expression And High Throughput ScreeningApplication PCTUS2016033348Pending
- High Throughput Screen For Biologically Active PolypeptidesApplication PCTUS2013024406Pending
- Domain Pair For Antibody ConstructsApplication PCTUS2026011161Pending
Related companies, and why
- NANOPHARMACEUTICALS, LLCSimilar federal contract value in Biotech · null in contracts
- Nerio TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Zafrens Inc.Similar federal contract value in Biotech · null in contracts
- LEUKOGENE THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- CERTICHEM, INC.Similar federal contract value in Biotech · null in contracts
- Viracta Subsidiary, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .